From: Efficacy of prophylactic splenectomy for proximal advanced gastric cancer invading greater curvature
Splenectomy (n = 63) | Spleen preservation (n = 45) | p value | |
---|---|---|---|
Clinical findings | |||
Age, median (range) | 64.0 (40–87) | 65.6 (20–89) | 0.416 |
Sex | 0.135 | ||
Male | 39 | 34 | |
Female | 24 | 11 | |
Depth of invasion | 0.769 | ||
cT2 | 29 | 22 | |
cT3–4 | 34 | 23 | |
Clinical N factor | 0.625 | ||
cN(−) | 31 | 20 | |
cN(+) | 32 | 25 | |
Borrmann macroscopic type | 0.196 | ||
Type 1 or 2 | 18 | 8 | |
Type 3, 4, or 5 | 45 | 37 | |
Histopathological type | 0.406 | ||
Intestinal | 23 | 20 | |
Diffuse | 40 | 25 | |
Operative findings | |||
Operative duration (min) | 297 | 277 | 0.660 |
(165–440) | (140–504) | ||
Blood loss (ml) | 538 | 450 | 0.016 |
(152–1900) | (10–1052) | ||
Curability | 0.973 | ||
Cur A | 24 | 17 | |
Cur B | 39 | 28 | |
Pathological findings | |||
Lymphatic invasion | 0.512 | ||
Negative | 16 | 9 | |
Positive | 47 | 36 | |
Venous invasion | 0.267 | ||
Negative | 10 | 11 | |
Positive | 53 | 34 | |
Lymph node metastasis | 0.746 | ||
pN0 | 23 | 16 | |
pN1 | 13 | 12 | |
pN2,3 | 27 | 17 | |
Pathological stage | 0.165 | ||
p stage I | 9 | 2 | |
p stage II | 18 | 21 | |
p stage III | 36 | 22 | |
Postoperative chemotherapy | 0.388 | ||
Yes | 49 | 38 | |
No | 14 | 7 |